The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Innate and Adaptive Immune System as Targets for Biologic Therapies in Inflammatory Bowel Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 10, Pages 2020
Publisher
MDPI AG
Online
2017-09-22
DOI
10.3390/ijms18102020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- European consensus conference on faecal microbiota transplantation in clinical practice
- (2017) Giovanni Cammarota et al. GUT
- Tofacitinib for induction and maintenance therapy of Crohn's disease: results of two phase IIb randomised placebo-controlled trials
- (2017) Julian Panés et al. GUT
- Inflammatory Bowel Disease: Updates on Molecular Targets for Biologics
- (2017) Konstantinos H. Katsanos et al. Gut and Liver
- Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme
- (2017) Violeta Razanskaite et al. Journal of Crohns & Colitis
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management
- (2017) Marcus Harbord et al. Journal of Crohns & Colitis
- Crosstalk between intestinal epithelial cell and adaptive immune cell in intestinal mucosal immunity
- (2017) Jun Tao Lu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
- (2017) Kristin K Jørgensen et al. LANCET
- Vedolizumab Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability Following Administration of a Single, Ascending, Intravenous Dose to Healthy Volunteers
- (2016) Maria Rosario et al. CLINICAL DRUG INVESTIGATION
- Differentiation of human innate lymphoid cells (ILCs)
- (2016) Kerstin Juelke et al. CURRENT OPINION IN IMMUNOLOGY
- Will novel oral formulations change the management of inflammatory bowel disease?
- (2016) Ole Haagen Nielsen et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- 812a Efficacy and Safety of Induction Therapy With the Selective IL-23 Inhibitor BI 655066, in Patients With Moderate-to-Severe Crohn's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Study
- (2016) Brian G. Feagan et al. GASTROENTEROLOGY
- 600 Multi Donor Intense Faecal Microbiota Transplantation is an Effective Treatment for Resistant Ulcerative Colitis: A Randomised Placebo-Controlled Trial
- (2016) Sudarshan Paramsothy et al. GASTROENTEROLOGY
- 812c Filgotinib (GLPG0634), an Oral JAK1 Selective Inhibitor, Induces Clinical Remission in Patients With Moderate-to-Severe Crohn's Disease: Results From the Phase 2 FITZROY Study Interim Analysis
- (2016) Severine Vermeire et al. GASTROENTEROLOGY
- 767 Efficacy and Safety of Oral Tofacitinib As Induction Therapy in Patients With Moderate to Severe Ulcerative Colitis: Results From Two Phase 3 Randomized Controlled Trials
- (2016) William Sandborn et al. GASTROENTEROLOGY
- The safety of vedolizumab for ulcerative colitis and Crohn's disease
- (2016) Jean-Frédéric Colombel et al. GUT
- Long-term Efficacy of Vedolizumab for Crohn’s Disease
- (2016) Severine Vermeire et al. Journal of Crohns & Colitis
- Long-term Efficacy of Vedolizumab for Ulcerative Colitis
- (2016) Edward V. Loftus et al. Journal of Crohns & Colitis
- Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis
- (2016) Raja Atreya et al. Journal of Crohns & Colitis
- ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease—An Update
- (2016) Silvio Danese et al. Journal of Crohns & Colitis
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial
- (2016) Julián Panés et al. LANCET
- Sphingosine-1-phosphate receptor-1 (S1P1) is expressed by lymphocytes, dendritic cells and endothelium and modulated during inflammatory bowel disease
- (2016) T Karuppuchamy et al. Mucosal Immunology
- Tocilizumab and the risk of intestinal perforation
- (2016) Lydia Shipman Nature Reviews Rheumatology
- Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis
- (2016) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease
- (2016) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mechanisms behind efficacy of tumor necrosis factor inhibitors in inflammatory bowel diseases
- (2016) Caroline Meyer Olesen et al. PHARMACOLOGY & THERAPEUTICS
- The association between the gut microbiota and the inflammatory bowel disease activity: a systematic review and meta-analysis
- (2016) Michelle Prosberg et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- The genetic burden of inflammatory bowel diseases: implications for the clinic?
- (2016) Tommaso Gabbani et al. Expert Review of Gastroenterology & Hepatology
- Ustekinumab in Crohn’s disease: evidence to date and place in therapy
- (2016) Tal Engel et al. Therapeutic Advances in Chronic Disease
- Randomised clinical trial: a placebo-controlled study of intravenous golimumab induction therapy for ulcerative colitis
- (2015) P. Rutgeerts et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management
- (2015) N. S. Ding et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Integrins and adhesion molecules as targets to treat inflammatory bowel disease
- (2015) Ivana Bravatà et al. CURRENT OPINION IN PHARMACOLOGY
- T cell subsets and their signature cytokines in autoimmune and inflammatory diseases
- (2015) Itay Raphael et al. CYTOKINE
- 830 Initial Evaluation of MEDI2070 (Specific Anti-IL-23 Antibody) in Patients With Active Crohn's Disease Who Have Failed Anti-TNF Antibody Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 2A Induction Study
- (2015) Bruce E. Sands et al. GASTROENTEROLOGY
- 901a A Randomized, Multicenter Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Anti-MAdCAM Antibody PF-00547659 (PF) in Patients With Moderate to Severe Ulcerative Colitis: Results of the TURANDOT Study
- (2015) Walter Reinisch et al. GASTROENTEROLOGY
- Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
- (2015) Paul Moayyedi et al. GASTROENTEROLOGY
- Proteolytic Cleavage and Loss of Function of Biologic Agents That Neutralize Tumor Necrosis Factor in the Mucosa of Patients With Inflammatory Bowel Disease
- (2015) Paolo Biancheri et al. GASTROENTEROLOGY
- 825 Anti-MAdCAM-1 Antibody (PF-00547659) for Active Refractory Crohn's Disease: Results of the OPERA Study
- (2015) William Sandborn et al. GASTROENTEROLOGY
- Improving safety of autologous haematopoietic stem cell transplantation in patients with Crohn's disease
- (2015) Aranzazu Jauregui-Amezaga et al. GUT
- Role for Therapeutic Drug Monitoring During Induction Therapy with TNF Antagonists in IBD
- (2015) Konstantinos Papamichael et al. INFLAMMATORY BOWEL DISEASES
- Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety
- (2015) Zhenhua Xu et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial
- (2015) Reena Khanna et al. LANCET
- Mongersen, an Oral SMAD7 Antisense Oligonucleotide, and Crohn’s Disease
- (2015) Giovanni Monteleone et al. NEW ENGLAND JOURNAL OF MEDICINE
- The involvement of gut microbiota in inflammatory bowel disease pathogenesis: Potential for therapy
- (2015) Giovanni Cammarota et al. PHARMACOLOGY & THERAPEUTICS
- Functional and Phenotypic Plasticity of CD4+T Cell Subsets
- (2015) Tiffany Caza et al. Biomed Research International
- How the Intricate Interaction among Toll-Like Receptors, Microbiota, and Intestinal Immunity Can Influence Gastrointestinal Pathology
- (2015) Simona Frosali et al. Journal of Immunology Research
- Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series
- (2015) Thomas Greuter et al. United European Gastroenterology Journal
- Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn's disease: 7-year results from the PRECiSE 3 study
- (2014) W. J. Sandborn et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2 and 3
- (2014) Jean-Frederic Colombel et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
- (2014) Bruce E. Sands et al. GASTROENTEROLOGY
- Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
- (2014) Silvio Danese et al. GUT
- Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
- (2014) Parambir S Dulai et al. GUT
- Incidence and Predictors of Clinical Response, Re-induction Dose, and Maintenance Dose Escalation with Certolizumab Pegol in Crohnʼs Disease
- (2014) Adam C. Stein et al. INFLAMMATORY BOWEL DISEASES
- Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: Safety, feasibility, and efficacy trial results
- (2014) Bota Cui et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Etrolizumab as induction therapy for ulcerative colitis: a randomised, controlled, phase 2 trial
- (2014) Séverine Vermeire et al. LANCET
- Physicochemical characterization of Remsima®
- (2014) Soon Kwan Jung et al. mAbs
- Discovery and characterization of olokizumab
- (2014) Stevan Shaw et al. mAbs
- Interleukin-33 and Inflammatory Bowel Diseases: Lessons from Human Studies
- (2014) Tiago Nunes et al. MEDIATORS OF INFLAMMATION
- Fecal Microbiota Transplantation in Inflammatory Bowel Disease
- (2014) Gianluca Ianiro et al. MEDICINE
- New targeted therapies such as anti-adhesion molecules, anti-IL-12/23 and anti-Janus kinases are looking toward a more effective treatment of inflammatory bowel disease
- (2014) Ivana Bravatà et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Immunopathology of inflammatory bowel disease
- (2014) Kori L Wallace WORLD JOURNAL OF GASTROENTEROLOGY
- Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections
- (2013) Christina M Surawicz et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Innate and adaptive immunity in inflammatory bowel disease
- (2013) Alessandra Geremia et al. AUTOIMMUNITY REVIEWS
- Anti-IL-13 in Inflammatory Bowel Disease: From the Bench to the Bedside
- (2013) Manol Jovani et al. CURRENT DRUG TARGETS
- Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
- (2013) Mariangela Allocca et al. CURRENT DRUG TARGETS
- Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
- (2013) William J. Sandborn et al. GASTROENTEROLOGY
- Altered Innate Defenses in the Neonatal Gastrointestinal Tract in Response to Colonization by Neuropathogenic Escherichia coli
- (2013) George M. H. Birchenough et al. INFECTION AND IMMUNITY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- P03-024 – Early onset IBD treated by tocilizumab
- (2013) R Helbling et al. Pediatric Rheumatology
- FOXP3+T Regulatory Cell Modifications in Inflammatory Bowel Disease Patients Treated with Anti-TNFαAgents
- (2013) Luisa Guidi et al. Biomed Research International
- Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response
- (2013) Gary R. Lichtenstein Therapeutic Advances in Gastroenterology
- Opposing Functions of Classic and Novel IL-1 Family Members in Gut Health and Disease
- (2013) Loris R. Lopetuso et al. Frontiers in Immunology
- Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective
- (2012) Fabien B Vincent et al. ANNALS OF THE RHEUMATIC DISEASES
- Evidence from Genetics for a Role of Autophagy and Innate Immunity in IBD Pathogenesis
- (2012) Miles Parkes DIGESTIVE DISEASES
- Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice
- (2012) Mamdouh A K Sedhom et al. GUT
- Exclusive antagonism of the α4β7 integrin by vedolizumab confirms the gut-selectivity of this pathway in primates
- (2012) Eric R. Fedyk et al. INFLAMMATORY BOWEL DISEASES
- Neutralization of Membrane TNF, but Not Soluble TNF, Is Crucial for the Treatment of Experimental Colitis
- (2012) Clémentine Perrier et al. INFLAMMATORY BOWEL DISEASES
- Mucin Function in Inflammatory Bowel Disease
- (2012) Doron Boltin et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Discovery and mechanism of ustekinumab
- (2012) Jacqueline M. Benson et al. mAbs
- Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease
- (2012) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Infliximab Therapy Inhibits Inflammation-Induced Angiogenesis in the Mucosa of Patients With Crohn's Disease
- (2011) Sergio Rutella et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- The Life and Death of Epithelia During Inflammation: Lessons Learned from the Gut
- (2011) Stefan Koch et al. Annual Review of Pathology-Mechanisms of Disease
- Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
- (2011) Zhenhua Xu et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes
- (2011) EG Stefanich et al. BRITISH JOURNAL OF PHARMACOLOGY
- Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases
- (2011) Warren Strober et al. GASTROENTEROLOGY
- Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammation
- (2011) Jessica M. Holmn Larsson et al. INFLAMMATORY BOWEL DISEASES
- Recommendations for Probiotic Use—2011 Update
- (2011) Martin H. Floch et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- IL-23–responsive innate lymphoid cells are increased in inflammatory bowel disease
- (2011) Alessandra Geremia et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
- (2011) Kamran Ghoreschi et al. JOURNAL OF IMMUNOLOGY
- Intestinal homeostasis and its breakdown in inflammatory bowel disease
- (2011) Kevin J. Maloy et al. NATURE
- Ulcerative Colitis
- (2011) Silvio Danese et al. NEW ENGLAND JOURNAL OF MEDICINE
- Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation
- (2011) Luca Pastorelli et al. Therapeutic Advances in Gastroenterology
- Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis
- (2010) Ayako Kobori et al. JOURNAL OF GASTROENTEROLOGY
- Erratum: Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo
- (2010) R Atreya et al. NATURE MEDICINE
- Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis
- (2010) Luca Pastorelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transmembrane TNF- : structure, function and interaction with anti-TNF agents
- (2010) T. Horiuchi et al. RHEUMATOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Remission induction and maintenance effect of probiotics on ulcerative colitis: A meta-analysis
- (2010) Li-Xuan Sang WORLD JOURNAL OF GASTROENTEROLOGY
- IL-33 and IL-33 Receptors in Host Defense and Diseases
- (2010) Keisuke Oboki et al. ALLERGOLOGY INTERNATIONAL
- A novel Toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis
- (2009) Ryan Ungaro et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Th1/Th17 Immune Response Is Induced by Mesenteric Lymph Node Dendritic Cells in Crohn's Disease
- (2009) Atsushi Sakuraba et al. GASTROENTEROLOGY
- TLR9 mRNA expression is upregulated in patients with active ulcerative colitis
- (2009) Fausto Sánchez-Muñoz et al. INFLAMMATORY BOWEL DISEASES
- Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease
- (2009) Caroll J. Beltrán et al. INFLAMMATORY BOWEL DISEASES
- IL-33 Induces IL-13-Dependent Cutaneous Fibrosis
- (2009) A. L. Rankin et al. JOURNAL OF IMMUNOLOGY
- Commensal DNA Limits Regulatory T Cell Conversion and Is a Natural Adjuvant of Intestinal Immune Responses
- (2008) Jason A. Hall et al. IMMUNITY
- Lymphoid tissue inducer–like cells are an innate source of IL-17 and IL-22
- (2008) Hiroaki Takatori et al. JOURNAL OF EXPERIMENTAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now